Keiichi Yoshimatsu

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Koide, Chiaki Kiyokawa, Anna Okishima, Kaito Saito, Keiichi Yoshimatsu, Tatsuya Fukuta, Yu Hoshino, Tomohiro Asai, Yuri Nishimura, Yoshiko Miura, Naoto Oku, Kenneth J Shea
Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy. Journal of the American Chemical Society (2023)
Keiichi Yoshimatsu, Krista R Fruehauf, Quanhong Zhu, Adam Weisman, Jun Fan, Min Xue, John M Beierle, Paul E Rose, Jennifer Aral, Linda F Epstein, Philip Tagari, Les P Miranda, Kenneth J Shea
Metal-Free Polymer-Based Affinity Medium for Selective Purification of His6-Tagged Proteins. Biomacromolecules 22 (4) (2021)
Hiroyuki Koide, Anna Okishima, Yu Hoshino, Yuri Kamon, Keiichi Yoshimatsu, Kazuhiro Saito, Ikumi Yamauchi, Saki Ariizumi, Yuqi Zhou, Ting-Hui Xiao, Keisuke Goda, Naoto Oku, Tomohiro Asai, Kenneth J Shea
Synthetic hydrogel nanoparticles for sepsis therapy. Nature communications 12 (1) (2021)

Keiichi Yoshimatsu.css-eqlu8i{font-size:small;padding-left:4px;}